Edita Botonjic-Sehic

Director of Analytics, Digital Innovation • Pall Corporation

Dr. Edita Botonjic-Sehic, a graduate of Assumption College with BA degrees in chemistry and mathematics and the University of Rhode Island with a PhD in the field of Analytical Chemistry. Dr. Botonjic-Sehic joined Pall Corporation in 2016 and is currently Director, Global Analytics, Biotechnology. In her current position, she is responsible for conceptualization and implementation of process analytical technology (PAT) in continuous bioprocessing. With a PhD program concentrating in spectroscopy and chemometrics and multiple years in PAT, Dr. Botonjic-Sehic brings a highly refined experience to the table. This experience includes over 16 years of research in spectroscopy and chemometrics for PAT and the development and utilization of advanced analytical techniques in pharmaceutical, biotechnolgoy and homeland security arenas.

Also Speaking

Patrick Westmoreland

Principal Scientist, Viral Vector and Gene Editing Process Development  • Bristol Myer Squibb

Daniel C. Smith

Executive Director, Global Cell & Gene Therapy Portfolio • Charles River

Matthew Li

Associate Director, Head of Cell Therapy Manufacturing Innovation • Vor Biopharma

Event Info


Fun Run